MedTrace Logo

A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo

NCT06804772 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-02-03

No results posted yet for this study

Summary

A clinical study with approximately 15 subjects, aged 35-65 years of age, who must have crow's feet and at least one other type of facial fine lines/wrinkles in order to evaluate the efficacy of Activated Silk™ 27P-α to improve the signs of aging, by comparing to a placebo.

Conditions

  • Skin Aging

Interventions

OTHER

Investigational Facial Serum #3

Investigational Facial Serum #3 is a placebo comparator

OTHER

Investigational Facial Serum #1

Investigational Facial Serum #1 is made with Activated Silk™ 27P-α.

OTHER

Investigational Facial Serum #2

Investigational Facial Serum #2 is made with an active comparator.

Sponsors & Collaborators

  • Victoria Collotta

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-03
Primary Completion
2025-01-03
Completion
2025-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06804772 on ClinicalTrials.gov